If you have been diagnosed with vision problems after regularly taking the medicine Elmiron® for bladder pain or osteoarthritis, you are not alone. You should seek trusted legal guidance about your legal options to seek compensation as soon as possible. You may be entitled to sue the drug manufacturer and demand compensation for the serious and possibly irreversible vision loss that you have suffered from taking Elmiron®.
Consumers have a right to trust that the prescription drugs they take are safe and effective and to be warned of any side effects. When a dangerously defective drug causes harm, the manufacturer should be held accountable. In recent months, many people have filed lawsuits against the maker of Elmiron® since medical researchers reported the connection between the medication and loss of vision. The attorneys at Joye Law Firm are reviewing potential Elmiron® lawsuits in South Carolina.
Our attorneys at Joye Law Firm are committed to standing up for South Carolinians who have been injured by Elmiron® or other unsafe drugs. We have been helping injured people in South Carolina hold pharmaceutical companies fully accountable for more than 50 years. We cannot guarantee any specific result from an Elmiron® vision loss lawsuit but our record of verdicts and settlements shows the energy and resources we put into each case and our depth of experience litigating complex product liability cases. Our law firm is gratified by the testimonials of former clients. It is a privilege to use our legal skills to help people who need a strong advocate.
Please call us at 877-941-1019 or contact us online to schedule a free consultation.
What is Elmiron?
Elmiron® is a medication approved by the Food and Drug Administration for relief of bladder pain and discomfort associated with interstitial cystitis, a chronic condition. Elmiron® has been on the market since the 1990s. It has recently been linked by multiple medical studies to serious retinal damage and vision loss among patients.
Janssen Pharmaceuticals is the maker of Elmiron®, which contains the active ingredient pentosane polysulfate sodium.
In December of 2020, a federal judicial panel transferred more than 100 Elmiron® lawsuits from throughout the U.S. to a federal court in New Jersey. The lawsuits will be handled as a multi-district litigation for more efficient handling of the pre-trial phases of the product liability cases.
The lawsuits contain issues in common involving the propensity of Elmiron® to cause retinal damage to users, including loss of vision. Grouping the cases together during the early stages reduces the cost of investigating the development and marketing of the medication and preparing the litigation for trial. More Elmiron® lawsuits, perhaps hundreds more, are expected to be filed in the coming months, the court said in centralizing the cases.
In addition to changes in eyesight and vision loss, a number of side effects have been reported by patients taking Elmiron®, most notably bleeding complications. Elmiron® is a weak blood thinner, which may increase bleeding events.
Other common side effects include:
- Diarrhea, upset stomach
- Bleeding complications
- Blood in stool
- Abnormal liver function test results
- Hair loss